Incyte recently announced that the European Commission (EC) has approved Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) ···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 112
In April 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Pemazyre (pemigatinib) oral tablets, developed by Incyte, f···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 103
Store palbociclib in its original blister pack at a temperature of 68°F to 77°F (20°C to 25°C).Keep the medication out of the reach of children.【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 107
Inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medications, vitamins, ···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 103
In the event of an accidental overdose of palbociclib, contact your healthcare provider immediately or proceed directly to the nearest hospital emerge···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 106
If you skip a dose of palbociclib or experience vomiting shortly after taking a dose, do not administer an additional dose on the same day. Resume you···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 118
On August 26, 2022, Incyte announced that the U.S. Food and Drug Administration (FDA) has approved Pemazyre (pemigatinib) for the treatment of adult p···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 108
The price of palbociclib is significantly affected by drug specifications, regional policies, and purchasing channels. In China, the price per box typ···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 110
On March 31, 2017, the U.S. Food and Drug Administration (FDA) granted palbociclib (IBRANCE, Pfizer) general approval for the treatment of hormone rec···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 128
The U.S. Food and Drug Administration (FDA) has approved Ibrance (palbociclib) for the treatment of advanced (metastatic) breast cancer.Breast cancer ···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 127
On March 31, 2017, the U.S. Food and Drug Administration (FDA) granted palbociclib (IBRANCE) general approval for the treatment of hormone receptor (H···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 109
Pfizer and the German Breast Group (GBG) recently announced that the Phase 3 PENELOPE-B trial of Ibrance (trade name: palbociclib) for the treatment o···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 110
Ibrance (palbociclib), developed by Pfizer, is the world's first CDK4/6 inhibitor to be marketed globally. It was first approved in February 2015 ···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 100
Certain drugs should not be used together due to safety risks. Some medications can alter blood concentrations of other drugs, which may heighten side···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 111
Do not drive or perform potentially dangerous tasks until you understand how mitotane affects you, as it may slow your reactions.【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 114
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



